• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Treating HER 2 positive metastatic breast cancer without chemotherapy?

  • in Oncology
  • — 9 Apr, 2013
Jose Baselga
Jose Baselga

WASHINGTON DC—Patients with metastatic breast cancer who are HER-2 positive could potentially be treated with the anti-HER-2 conjugated drug, trastuzumab-emtansine (T-DM1), alone — without needing to add chemotherapy. This prediction was made at the American Association for Cancer Research annual conference by Dr Jose Baselga Physician in Chief at New York’s Memorial Sloan-Kettering Cancer Center on the basis of data the EMILIA study (which led to the approval of this agent in the USA in 2013). He gave Peter Goodwin details about the effectiveness of this new agent in the presence of PI-3 kinase mutations.

You may also like...

  • Audio Journal of Oncology in Advance – December 1st, 2006 Audio Journal of Oncology in Advance – December 1st, 2006 1 Dec, 2006
  • Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone 1 Feb, 2008
  • ASCO Annual Meeting Daily News Podcasts – June 5th, 2007 ASCO Annual Meeting Daily News Podcasts – June 5th, 2007 5 Jun, 2007
  • Idelalisib: new targeted therapy improves outlook for patients with chronic lymphocytic leukaemia Idelalisib: new targeted therapy improves outlook for patients with chronic lymphocytic leukaemia 24 Jan, 2014

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Two-step immunotherapy brings promise in advanced ovarian cancer
  • Next story Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with…
    • Which New Combination for Metastatic Renal Cell Cancer?
  • Home
  • Oncology
  • Treating HER 2 positive metastatic breast cancer without chemotherapy?

© COPYRIGHT 2020 AUDIOMEDICA.COM.